These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6742767)

  • 1. Radioimaging of the prostate and metastases of prostatic carcinoma with 99mTc-labelled prostatic acid phosphatase-specific antibodies and their Fab fragments.
    Vihko P; Heikkilä J; Kontturi M; Wahlberg L; Vihko R
    Ann Clin Res; 1984; 16(1):51-2. PubMed ID: 6742767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
    Goldenberg DM; DeLand FH
    Urol Clin North Am; 1984 May; 11(2):277-81. PubMed ID: 6328719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimaging of lymph node involvement in prostatic carcinoma.
    Kontturi M; Lukkarinen O; Vihko P; Vihko R
    Scand J Urol Nephrol Suppl; 1988; 110():113-7. PubMed ID: 3187398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo.
    Leroy M; Teillac P; Rain JD; Saccavini JC; Le Duc A; Najean Y
    Cancer; 1989 Jul; 64(1):1-5. PubMed ID: 2731106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351).
    Chengazi VU; Feneley MR; Ellison D; Stalteri M; Granowski A; Granowska M; Nimmon CC; Mather SJ; Kirby RS; Britton KE
    J Nucl Med; 1997 May; 38(5):675-82. PubMed ID: 9170426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinoma.
    Vihko P; Kontturi M; Lukkarinen O; Martikainen P; Pelliniemi L; Heikkilä J; Vihko R
    Prostate; 1987; 11(1):51-7. PubMed ID: 3309904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
    Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
    Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
    Rost A; Fiedler U; Marshall F; Koppenhagen K
    Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].
    Pabst HW; Langhammer H; Schmid L; Sintermann R
    Rofo; 1981 Jul; 135(1):44-9. PubMed ID: 6288532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
    Haddock G; Gray HW; McKillop JH; Bessent RG; Kirk D
    Br J Urol; 1989 May; 63(5):497-502. PubMed ID: 2731008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.
    Reikerås O; Due J; Sundsfjord JA
    Int Urol Nephrol; 1988; 20(1):51-4. PubMed ID: 3283071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m DMSA uptake by metastatic carcinoma of the prostate.
    Lamki L; Shearer R
    J Nucl Med; 1984 Jun; 25(6):733-4. PubMed ID: 6327947
    [No Abstract]   [Full Text] [Related]  

  • 13. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
    Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
    Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial bone scanning in the evaluation of stage and clinical course in carcinoma of the prostate.
    Johansson JE; Beckman KW; Lindell D; Lingårdh ; Rydman H; Vikterlöf KJ
    Scand J Urol Nephrol Suppl; 1980; 55():31-6. PubMed ID: 6938033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of bone scanning in the assessment of prostatic carcinoma.
    McGregor B; Tulloch AG; Quinlan MF; Lovegrove F
    Br J Urol; 1978 May; 50(3):178-81. PubMed ID: 753456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer of the prostate: value of bone scintigraphy. Point of view].
    Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
    Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of bone metastases from carcinoma of the prostate by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)].
    Bussaka H; Fujimura N; Yamasaki K
    Kaku Igaku; 1980 Apr; 17(3):297-303. PubMed ID: 7392308
    [No Abstract]   [Full Text] [Related]  

  • 18. Misleading renal stasis on bone scintigraphy in diffuse symmetrical skeletal metastases of prostatic carcinoma.
    Kalin B; Jacobsson H
    Rofo; 1987 Oct; 147(4):465-6. PubMed ID: 2825278
    [No Abstract]   [Full Text] [Related]  

  • 19. Complex treatment and care of prostatic carcinoma patients.
    Frang D; Hübler J
    Acta Chir Hung; 1987; 28(3):167-75. PubMed ID: 3116795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
    Yuksel M; Cermik TF; Kaya M; Salan A; Ustun F; Salihoglu YS; Yigitbasi ON; Berkarda S
    Clin Nucl Med; 2001 Nov; 26(11):962. PubMed ID: 11595863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.